Skip to main content

Advertisement

SpringerLink
Log in

Management of respiratory symptoms in ALS

  • Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Respiratory insufficiency is a frequent feature of ALS and is present in almost all cases at some stage of the illness. It is the commonest cause of death in ALS. FVC is used as important endpoint in many clinical trials, and in decision-making events for patients with ALS, although there are limitations to its predictive utility. There are multiple causes of respiratory muscle failure, all of which act to produce a progressive decline in pulmonary function. Diaphragmatic fatigue and weakness, coupled with respiratory muscle weakness, lead to reduced lung compliance and atelectasis. Increased secretions increase the risk of aspiration pneumonia, which further compromises respiratory function. Bulbar dysfunction can lead to nutritional deficiency, which in turn increases the fatigue of respiratory muscles. Early recognition of respiratory decline and symptomatic intervention, including non-invasive ventilation can significantly enhance both quality of life and life expectancy in ALS. Patients with respiratory failure should be advised to consider an advance directive to avoid emergency mechanical ventilation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC (2009) Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73(15):1218–1226

    Article  PubMed  CAS  Google Scholar 

  2. Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, Hauw JJ, Meininger V (2008) Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler 9(1):59–62

    Article  PubMed  Google Scholar 

  3. Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG (2009) Eurals consortium. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10(5–6):310–323

    Article  PubMed  Google Scholar 

  4. Koritnik B, Azam S, Andrew CM, Leigh PN, Williams SC (2009) Imaging the brain during sniffing: a pilot fMRI study. Pulm Pharmacol Ther 22(2):97–101

    Article  PubMed  CAS  Google Scholar 

  5. Evans KC, Shea SA, Saykin AJ (1999) Functional MRI localisation of central nervous system regions associated with volitional inspiration in humans. J Physiol 520(Pt 2):383–392

    Article  PubMed  CAS  Google Scholar 

  6. Ramsay SC, Adams L, Murphy K, Corfield DR, Grootoonk S, Bailey DL, Frackowiak RS, Guz A (1993) Regional cerebral blood flow during volitional expiration in man: a comparison with volitional inspiration. J Physiol 461:85–101

    PubMed  CAS  Google Scholar 

  7. Shimizu T, Komori T, Kugio Y, Fujimaki Y, Oyanagi K, Hayashi H (2010) Electrophysiological assessment of corticorespiratory pathway function in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11(1–2):57–62

    Article  PubMed  Google Scholar 

  8. de Carvalho M, Swash M (2010) Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study. Muscle Nerve 41(2):208–211

    PubMed  Google Scholar 

  9. Atalaia A, De Carvalho M, Evangelista T, Pinto A (2007) Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function. Amyotroph Lateral Scler 8(2):101–105

    Article  PubMed  Google Scholar 

  10. Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (2010) ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler 11(4):379–382

    Article  PubMed  Google Scholar 

  11. Phukan J, Pender N, Hardiman O. Cognitive Dysfunction in ALS Lancet Neurology 2007

  12. Elman LB, Siderowf A, Houseman G, Kelley M, McCluskey LF (2005) Venous thrombosis in an ALS population over four years. Amyotroph Lateral Scler Other Motor Neuron Disord 6(4):246–249

    Article  PubMed  CAS  Google Scholar 

  13. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256(8):1236–1242

    Article  PubMed  CAS  Google Scholar 

  14. Fallat RJ, Jewitt B, Bass M, Kamm B, Norris FH Jr (1979) Spirometry in amyotrophic lateral sclerosis. Arch Neurol 36:74–80

    PubMed  CAS  Google Scholar 

  15. Czaplinski A, Yen AA, Appel SH (2006) Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 77:390–392

    Article  PubMed  CAS  Google Scholar 

  16. Stambler N, Charatan M, Cedarbaum JM (1998) Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 50:66–72

    PubMed  CAS  Google Scholar 

  17. Sanjak M, Salachas F, Frija-Orvoen E, Theys P, Hutchinson D, Verheijde J, Pianta T, Stewart H, Brooks BR, Meininger V, Douillet P (2010) Xaliproden [SR57746A] ALS International Study Group. Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11(4):383–388

    Article  PubMed  CAS  Google Scholar 

  18. Lanka V, Cudkowicz M (2008) Therapy development for ALS: lessons learned and path forward. Amyotroph Lateral Scler 9(3):131–140

    Article  PubMed  CAS  Google Scholar 

  19. Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson M, Douglas JA, Robinson PJ, McCombe PA (2010) Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11(1–2):194–202

    Google Scholar 

  20. Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW (2005) Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 171(3):269–274

    Article  PubMed  Google Scholar 

  21. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J (2001) Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 124:2000–2013

    Article  PubMed  CAS  Google Scholar 

  22. Pinto S, Pinto A, Atalaia A, Peralta R, de Carvalho M (2007) Respiratory apraxia in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 8(3):180–184

    Article  PubMed  Google Scholar 

  23. Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, Myers D, Heberlin L, King R, Smith J, Gelinas D, Miller RG (2001) A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci 191(1–2):75–78

    Article  PubMed  CAS  Google Scholar 

  24. Pinto S, Geraldes R, Vaz N, Pinto A, de Carvalho M (2009) Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clin Neurophysiol 120(12):2082–2085

    Article  PubMed  Google Scholar 

  25. Pinto S, Turkman A, Pinto A, Swash M, de Carvalho M (2009) Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies. Clin Neurophysiol 120(5):941–946

    Article  PubMed  Google Scholar 

  26. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B (2007) EALSC Working Group. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler 8(4):195–213

    Article  PubMed  Google Scholar 

  27. Sancho J, Servera E, Díaz J, Marín J (2004) Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest 125(4):1400–1405

    Article  PubMed  Google Scholar 

  28. Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM (1999) A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 169(1–2):118–125

    Article  PubMed  CAS  Google Scholar 

  29. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5(2):140–147

    Article  PubMed  Google Scholar 

  30. Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ (2003) Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 61(2):171–177

    PubMed  CAS  Google Scholar 

  31. Radunovic A, Annane D, Jewitt K, Mustfa N (2009) Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 7(4):CD004427

    Google Scholar 

  32. Pinto S, De Carvalho M (2010) Is a four-hour use of non-invasive ventilation enough to define compliance? Amyotroph Lateral Scler 11(1–2):250–252

    Article  PubMed  Google Scholar 

  33. Gruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL (2005) Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve 32(6):808–811

    Article  PubMed  CAS  Google Scholar 

  34. Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, Kohn MA, Lomen-Hoerth C (2005) The effects of executive and behavioral dysfunction on the course of ALS. Neurology 65(11):1774–1777

    Article  PubMed  CAS  Google Scholar 

  35. Onders RP, Elmo M, Khansarinia S, Bowman B, Yee J, Road J, Bass B, Dunkin B, Ingvarsson PE, Oddsdóttir M (2009) Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc 23(7):1433–1440

    Article  PubMed  Google Scholar 

  36. Borasio GD, Shaw PJ, Hardiman O, Ludolph AC, Sales Luis ML, Silani V (2001) European ALS Study Group. Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotroph Lateral Scler Other Motor Neuron Disord 2(3):159–164

    Google Scholar 

  37. Borasio GD, Gelinas DF, Yanagisawa N (1998) Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol 245(Suppl 2):S7–S12 discussion S29

    Article  PubMed  Google Scholar 

  38. Schlamp V, Karg O, Abel A, Schlotter B, Wasner M, Borasio GD (1998) Noninvasive intermittent self-ventilation as a palliative measure in amyotrophic lateral sclerosis. Nervenarzt 69(12):1074–1082

    Article  PubMed  CAS  Google Scholar 

  39. Neudert C, Oliver D, Wasner M, Borasio GD (2001) The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 248(7):612–616

    Article  PubMed  CAS  Google Scholar 

  40. Meyer T, Dullinger JS, Münch C, Keil JP, Hempel E, Rosseau S, Borisow N, Linke P (2008) Elective termination of respiratory therapy in amyotrophic lateral sclerosis. Nervenarzt 79(6):684–690

    Article  PubMed  CAS  Google Scholar 

  41. Borasio GD, Voltz R (1998) Discontinuation of mechanical ventilation in patients with amyotrophic lateral sclerosis. J Neurol 245(11):717–722

    Article  PubMed  CAS  Google Scholar 

  42. Albert SM, Whitaker A, Rabkin JG, del Bene M, Tider T, O’Sullivan I, Mitsumoto H (2009) Medical and supportive care among people with ALS in the months before death or tracheostomy. J Pain Symptom Manage 38(4):546–553

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. HRB Clinician Scientist, Trinity College and Beaumont Hospital, Dublin, Ireland

    Orla Hardiman

Authors
  1. Orla Hardiman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Orla Hardiman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hardiman, O. Management of respiratory symptoms in ALS. J Neurol 258, 359–365 (2011). https://doi.org/10.1007/s00415-010-5830-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5830-y

Keywords

Search

Navigation